Dr. Rongpeng Li | Molecular Biology | Research Excellence Award

Nantong University | China

Dr. Rongpeng Li is a highly productive researcher whose scientific contributions span molecular microbiology, innate immunity, tumor biology, and therapeutic drug discovery. With a publication record of 60 Scopus-indexed documents, an h-index of 20, and 1541 citations, his work demonstrates sustained impact across both fundamental life science and translational biomedical research. He has led 7 completed or ongoing research projects, in addition to 6 industry-linked consultancy projects, highlighting his strong engagement with applied science. His research focuses on the molecular mechanisms by which the innate immune system recognizes pathogens, regulates virulence, and interacts with host defense pathways, contributing to new insights into immune regulation and pathogen evolution. He has also advanced the understanding of tumor proliferation, resistance mechanisms, CAR-T/CAR-M therapies, and the influence of the tumor and gut microbiome on cancer progression. His contributions to natural drug discovery include identifying new immune-modulating compounds and developing therapeutic vaccine strategies. Notably, his team discovered that TRIM7 promotes NAFLD/NASH progression through DUSP10 degradation, establishing a novel regulatory axis for metabolic liver disease and identifying a promising therapeutic target. With strong publication output, innovation in drug discovery, and leadership in interdisciplinary collaborations, Dr. Li stands as a significant contributor to contemporary life science research.

Profiles: Scopus | Orcid 

Featured Publications

Yan, F.-J., Ding, H., Zhang, N., Yan, S.-R., Huang, M.-X., Lu, J.-W., Wang, Y.-J., Yan, Y.-J., Li, R.-P., & Wang, Q. The E3 ligase tripartite motif 7 drives the progression of non-alcoholic fatty liver disease by targeting DUSP10 degradation in male mice.

Wang, Z., Zhao, J., He, S., Li, R., Wang, X., Yan, C., Zhao, J., & Wei, W.  Inorganic polyphosphate relieves ulcerative colitis by modulating the gut microbiota and metabolites.

Song, L., Wang, S., Zou, H., Yi, X., Jia, S., Li, R., & Song, J. Regulation of ergosterol biosynthesis in pathogenic fungi: Opportunities for therapeutic development. .

Song, J., Shi, L., Wang, S., Wang, Y., Zhu, Y., Jiang, J., & Li, R. Correction for Song et al., “Acidic/alkaline stress mediates responses to azole drugs and oxidative stress in Aspergillus fumigatus”.

Rongpeng Li | Molecular Biology | Research Excellence Award

You May Also Like